Imatinib Induced Delayed and Refractory Generalized Fluid Retention - A Case Report and Review of Literature

Bader A Abdelmaksoud, Yaser Gad and Fayez G Alruwaily
Additional contact information
Bader A Abdelmaksoud: King Abdulaziz Specialist Hospital, Egypt
Yaser Gad: King Abdulaziz Specialist Hospital, Egypt
Fayez G Alruwaily: King Abdulaziz Specialist Hospital, Egypt

Biomedical Journal of Scientific & Technical Research, 2019, vol. 19, issue 1, 14004-14007

Abstract: Imatinib is a tyrosine kinase inhibitor used mainly for ABL-BCR positive CML. Development of fluid retention(FR) following imatinib therapy is the most common side effec...

Keywords: Biomedical Sciences; Biomedical Research; Technical Research; Imatinib; FR; CML; Tyrosine Kinase Inhibitors; BCR-ABL; CD117 (search for similar items in EconPapers)
Date: 2019
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://biomedres.us/pdfs/BJSTR.MS.ID.003233.pdf (application/pdf)
https://biomedres.us/fulltexts/BJSTR.MS.ID.003233.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:abf:journl:v:19:y:2019:i:1:p:14004-14007

DOI: 10.26717/BJSTR.2019.19.003233

Access Statistics for this article

Biomedical Journal of Scientific & Technical Research is currently edited by Robert Thomas

More articles in Biomedical Journal of Scientific & Technical Research from Biomedical Research Network+, LLC
Bibliographic data for series maintained by Angela Roy ().